Answers are grounded in this paper and cite their sources.
Metabolic comorbidities in CHB patients are associated with an increased risk for liver-related events, with the highest risk observed in patients with multiple comorbidities. Findings were consistent in various clinically relevant subgroups, underscoring the need for thorough metabolic assessment in patients with CHB.
No takes yet. Share an insight, caveat, or question.
Patmore et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: